inavir overtakes tamiflu in terms of no. sold

http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou01/dl/jichitai20140219-01.pdf

In case you do not understand the japanese, you use google translator.

In my memory, it was the first time shown that the number of Inavir supplied to clinics overtook that of Tamiflu in Japan. 94.9 (0000) Vs 84.7 (0000). the time frame is from 06/01 to 02/02 .

Just wonder what share of profit Biota will get from Lani ROW. When the previous management signed the agreement with DS regarding the Inavir profit shares in Japan, the lani profit shares in the ROW should also be mentioned for later use. I hope the previous management was not that dumb so that DS still had 50% of Lani profit in the ROW even Biota chooses to develop Lani ROW by itself.

Japanese government still has no Inavir in its flu antiviral stockpiles.